Literature DB >> 25695174

In-hospital transfer is a risk factor for invasive filamentous fungal infection among hospitalized patients with hematological malignancies: a matched case-control study.

Angèle Gayet-Ageron1, Anne Iten1, Christian van Delden2, Natacha Farquet1, Stavroula Masouridi-Levrat3, Elodie Von Dach1, Yves Chalandon3, Didier Pittet1.   

Abstract

OBJECTIVE: Immunocompromised patients now benefit from a longer life expectancy due to advanced medical techniques, but they are also weakened by aggressive treatment approaches and are at high risk for invasive fungal disease. We determined risk factors associated with an outbreak of invasive filamentous fungal infection (IFFI) among hospitalized hemato-oncological patients.
METHODS: A retrospective, matched, case-control study was conducted between January 1, 2009, and April 31, 2011, including 29 cases (6 proven, 8 probable, and 15 possible) of IFFI and 102 matched control patients hospitalized during the same time period. Control patients were identified from the hospital electronic database. Conditional logistic regression was performed to identify independent risk factors for IFFI.
RESULTS: Overall mortality associated with IFFI was 20.7% (8.0%-39.7%). Myelodysplastic syndrome was associated with a higher risk for IFFI compared to chronic hematological malignancies. After adjustment for major risk factors and confounders, >5 patient transfers outside the protected environment of the hematology ward increased the IFFI risk by 6.1-fold. The risk increased by 6.7-fold when transfers were performed during neutropenia.
CONCLUSION: This IFFI outbreak was characterized by a strong association with exposure to the unprotected environment outside the hematology ward during patient transfer. The independent associations of a high number of transfers with the presence of neutropenia suggest that affected patients were probably not sufficiently protected during transport in the corridors. Our study highlights that a heightened awareness of the need for preventive measures during the entire care process of at-risk patients should be promoted among healthcare workers.

Entities:  

Mesh:

Year:  2015        PMID: 25695174     DOI: 10.1017/ice.2014.69

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  4 in total

Review 1.  Primary antifungal prophylaxis during curative-intent therapy for acute myeloid leukemia.

Authors:  Anna B Halpern; Gary H Lyman; Thomas J Walsh; Dimitrios P Kontoyiannis; Roland B Walter
Journal:  Blood       Date:  2015-10-26       Impact factor: 22.113

2.  Seasonal clustering of sinopulmonary mucormycosis in patients with hematologic malignancies at a large comprehensive cancer center.

Authors:  Shobini Sivagnanam; Dhruba J Sengupta; Daniel Hoogestraat; Rupali Jain; Zach Stednick; David N Fredricks; Paul Hendrie; Estella Whimbey; Sara T Podczervinski; Elizabeth M Krantz; Jeffrey S Duchin; Steven A Pergam
Journal:  Antimicrob Resist Infect Control       Date:  2017-12-06       Impact factor: 4.887

3.  Invasive Mold Infections in Allogeneic Hematopoietic Cell Transplant Recipients in 2020: Have We Made Enough Progress?

Authors:  Romain Samuel Roth; Stavroula Masouridi-Levrat; Yves Chalandon; Anne-Claire Mamez; Federica Giannotti; Arnaud Riat; Adrien Fischer; Antoine Poncet; Emmanouil Glampedakis; Christian Van Delden; Laurent Kaiser; Dionysios Neofytos
Journal:  Open Forum Infect Dis       Date:  2021-11-29       Impact factor: 3.835

4.  Chemotherapy-related infectious complications in patients with Hematologic malignancies.

Authors:  Raluca-Ana Rusu; Dana Sîrbu; Daniela Curşeu; Bogdana Năsui; Mădălina Sava; Ştefan Cristian Vesa; Anca Bojan; Cosmin Lisencu; Monica Popa
Journal:  J Res Med Sci       Date:  2018-07-26       Impact factor: 1.852

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.